# Metastatix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metastatix

- Industry: Pharmaceuticals
- Headquarters: Atlanta, US
- Website: www.altiristherapeutics.com
- Total disclosed funding: $39M
- Latest round: Series B (Sep 14, 2007)
- Investors on record: 8

## About

Founded in 2005, Metastatix Inc. is a pharmaceutical company, engages in developing and commercializing small-molecule drug therapies

## Funding rounds

- Series B, Sep 14, 2007, $35M — Aurora Funds, Frazier Healthcare Partners, SR One, H.I.G. BioHealth Partners, CM Capital Investments, Georgia Venture Partners, MedImmune Ventures, Centrosome Ventures
- Series A, Sep 7, 2006, $3.6M — Aurora Funds, SR One, H.I.G. BioHealth Partners, CM Capital Investments, Georgia Venture Partners, MedImmune Ventures, Centrosome Ventures
- Seed, Apr 1, 2005, $0.5M — Georgia Venture Partners

## Investors

- Georgia Venture Partners (https://capitalatlas.ai/funds/georgia-venture-partners) — Seed, Series A, Series B
- Aurora Funds (https://capitalatlas.ai/funds/aurora-funds) — Series A, Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A, Series B
- H.I.G. BioHealth Partners (https://capitalatlas.ai/funds/h-i-g-biohealth-partners) — Series A, Series B
- CM Capital Investments — Series A, Series B
- MedImmune Ventures (https://capitalatlas.ai/funds/medimmune-ventures) — Series A, Series B
- Centrosome Ventures — Series A, Series B
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series B